Open Access

PCSK9 inhibitors: the evidence-based story

Event: ESC CONGRESS 2017
Topic: Atherosclerosis
Session type: Satellite Symposium - Experts on the Spot
Sponsored by Amgen GmbH
Date: 29 August 2017
Time: 15:45 - 16:15

Congress Session

3 presentations in this session

PCSK9 inhibitors: the story retold.

Speaker: Professor C. Packard (Glasgow, GB)
Speaker: Professor S. Nicholls (Melbourne, AU)
Thumbnail

PCSK9 inhibitors: panel discussion.

Speaker: Professor C. Packard (Glasgow, GB)
Speaker: Professor S. Nicholls (Melbourne, AU)
Thumbnail

PCSK9: the story unfolds.

Speaker: Professor C. Packard (Glasgow, GB)
Thumbnail

5 speakers from this session

Professor Chris Packard

, Glasgow (United Kingdom of Great Britain & Northern Ireland)
7 presentations
0 follower

Professor Stephen Nicholls

Monash Heart, Melbourne (Australia)
36 presentations
2 followers

Professor Chris Packard

, Glasgow (United Kingdom of Great Britain & Northern Ireland)
7 presentations
0 follower

Professor Stephen Nicholls

Monash Heart, Melbourne (Australia)
36 presentations
2 followers

Professor Chris Packard

, Glasgow (United Kingdom of Great Britain & Northern Ireland)
7 presentations
0 follower

This platform is supported by

logo Novo Nordisk